Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Optimizing drug combinations to resurrect the potency of failed antibody therapy against emerging COVID-19 variants using IDentif.AI.

Frontiers in digital health·2026
Same author

Perspectives from healthcare providers and decision-makers on strategies toward a future hospital: qualitative insights from a group modelling process.

BMC health services research·2026
Same author

Propensity score matched comparison of pancreatoduodenectomy with pancreatogastrostomy versus pancreatojejunostomy: A single institution experience shifting from pancreatogastrostomy to pancreatojejunostomy.

Annals of hepato-biliary-pancreatic surgery·2026
Same author

The role of histone demethylase PHF2 as a tumour suppressor in hepatocellular carcinoma by regulating SRXN1.

Oncogenesis·2026
Same author

The functional imperative in high-grade glioma.

Experimental & molecular medicine·2026
Same author

Artificial intelligence for breast cancer management.

Communications medicine·2026

相关实验视频

Updated: May 21, 2025

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

9.5K

功能组合精准医学用于预测和优化软组织肉瘤治疗方法.

Sharon Pei Yi Chan1, Masturah Bte Mohd Abdul Rashid2, Jhin Jieh Lim2

  • 1Cancer Science Institute of Singapore, National University of Singapore, 14 Medical Drive, #12-01 Centre for Translational Medicine, Singapore, 117599, Republic of Singapore.

NPJ precision oncology
|March 23, 2025
PubMed
概括

这项研究表明,正方形表型优化平台 (QPOP) 可以预测软组织肉瘤 (STS) 治疗反应. QPOP确定了一种新型药物组合,对STS患者具有更高的疗效.

更多相关视频

Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

6.8K
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.1K

相关实验视频

Last Updated: May 21, 2025

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

9.5K
Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

6.8K
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.1K

科学领域:

  • 在瘤学瘤学.
  • 药理学 药理学 是一个学科.
  • 生物技术是生物技术.

背景情况:

  • 软组织肉瘤 (STS) 是一种罕见的,异质的癌症,预后不佳.
  • 目前的治疗方法,主要是细胞毒性化疗,由于缺乏向疗法,其疗效有限.

研究的目的:

  • 评估二次现象优化平台 (QPOP) 用于预测STS的治疗反应.
  • 探索QPOP在为STS设计有效的组合疗法的实用性.

主要方法:

  • QPOP被用来选45个STS患者的原发性样本,以对抗各种药物.
  • 药物敏感性数据与患者的治疗结果相关.
  • 鉴定并验证了AZD5153 (BET抑制剂) 和帕佐帕尼布 (多酶抑制剂) 的组合.

主要成果:

  • QPOP预测显示了改善或一致的患者结果.
  • 与标准治疗方案相比,鉴定的药物组合显示出更高的疗效.
  • 在体外和体外模型证实了MYC通路的协同相互作用和抑制.

结论:

  • QPOP显示承诺作为STS治疗反应的预测工具.
  • 这个平台可以指导开发新的,有效的STS组合疗法.
  • 初步的临床证据支持QPOP在个性化STS治疗策略中的作用.